Innovative animal-free cell culture improves consistency, safety and efficiency Berlin, Germany – InVitria, a division of Ventria Bioscience, has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany. Leveraging Ventria’s proprietary ExpressTec technology, InVitria has developed and commercialized eight recombinant proteins and cell culture media supplements made in a completely animal-free system. Animal-component […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early […]
Walkersville, MD (USA) / Basel (CH) – Today Lonza Walkersville announced its new offering of Silensomes™ Human Liver Microsomes (HLM) products – pooled human liver microsomes for in vitro cytochrome P450 (CYP) phenotyping. CYP phenotyping is a regulatory requirement for new drug candidates to understand their metabolism and to predict drug-drug interactions. Lonza Walkersville’s new Silensomes™ HLM products provide […]
Collaboration aimed at developing novel “Nephron-on-a-Chip” device to test drug candidates in human kidney: NEPLEX (“NEPHRON-ON-A-CHIP WITH CELLULAR AND EXTRACELLULAR MATRIX COMPLEXITY”) Major step forward to the next generation kidney platform Hamburg, Germany: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a strategic collaboration on microfluidics technology including induced pluripotent stem cell […]
As of October 2017 Micronit, Axxicon and Helvoet are collaborating in offering a market leading development and manufacturing package to support the growing global demand for high volume polymer microfluidic products. The strong market growth is driven by the new fast diagnostic systems being developed and entering the health care market. At the same time […]
Applied StemCell, Inc., a global provider of gene editing and stem cell-based services, as well as a leader in molecular and cellular reference standard products for clinical diagnostics markets, is proud to receive certifications for two International Organization for Standardization (ISO) Quality Management Systems (QMS) on October 20, 2017, the ISO 9001:2015 and 13485:2016. The […]
SAN DIEGO — Organovo Holdings, Inc.(NASDAQ:ONVO) (“Organovo”) and Viscient Biosciences (“Viscient”) today announced a collaboration to develop a custom research platform for studying liver disease. The partnership is expected to expand upon Organovo’s current service portfolio for compound screening in disease models, which aids the drug discovery work of the Company’s customers. Viscient is targeting early discovery […]
SHANGHAI, China and CUPERTINO, Calif. — Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and effective stem cell therapies for degenerative diseases, today announced the establishment of a strategic partnership with Thermo Fisher Scientific (China) Ltd. (Thermo Fisher) to build a […]
Fluicell AB is extremely pleased to announce the signing of a license agreement with Cellectricon AB, granting the exclusive right, inter alia , to sell the Dynaflow Resolve technology worldwide and to use the related IP rights. The Dynaflow Resolve system is considered by many, to be the premier secondary ion channel screening platform on the market, […]
Key appointments follow on Series A financing to support the commercialization and distribution of the world’s first precision genomics platform for high throughput single-cell DNA analysis SOUTH SAN FRANCISCO, Calif.—Mission Bio, Inc., a leader in single-cell analysis and precision genomics, today announced new additions to the senior management team as the company scales and commercializes […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
